CVS Health Q4营收及调整后每股收益均超预期，重申今年业绩指引

Group 1 - CVS Health reported Q4 2025 revenue growth of over 8% to $105.7 billion, exceeding analyst expectations of $103.59 billion [1] - Adjusted earnings per share decreased by over 8% to $1.09, also surpassing analyst expectations of $0.99 [1] - For 2026, the company reaffirmed its revenue guidance of at least $400 billion and maintained adjusted earnings per share expectations between $7 and $7.20 [1]